CITIC Capital
Hidden Hill leads $330m round for Geely's China NEV unit
Farizon Auto, a new energy vehicle (NEV) brand under Chinese automaker Geely, has secured USD 300m in pre-Series A funding led by Hidden Hill Capital, a private equity arm of local warehouse operator turned logistics and infrastructure investment manager...
Qihoo leads $630m round for China EV maker Hozon
China security software provider Qihoo 360 Technology has led a RMB4 billion ($630 million) round for Hozon Auto, a local electric Vehicle (EV) manufacturer, making an individual contribution of RMB2 billion.
GIC invests $240m in Arctic Green Energy
Singapore sovereign wealth fund GIC has committed $240 million to Arctic Green Energy (AGE), an Iceland-based geothermal energy developer that has already received substantial Chinese backing.
PE investors complete $4.6b China Biologic take-private
An investor group including Centurium Capital, CITIC Capital and Hillhouse Capital has completed its protracted pursuit of China Biologic Products Holdings with a $4.6 billion privatization.
Trustar to launch China growth strategy
Trustar Capital, a Chinese middle-market private equity firm until recently known as CITIC Capital, is complementing its flagship buyout strategy with a growth capital-oriented fund.
China yogurt brand secures $122m Series B
Simple Love, also known as Jian’Ai, a Chinese yogurt brand, has raised RMB800 million ($122 million) in Series B funding from Matrix Partners China, BA Capital, CITIC Agriculture Fund, and Maison Capital. They all backed the company's RMB400 million...
CITIC Capital rebrands as Trustar, backs Swiss medtech business
CITIC Capital Partners, a private equity firm part-owned by Chinese conglomerate CITIC Group, has rebranded as Trustar Capital.
China's CITIC sells US dental business
CITIC Capital Partners has exited US-based dental business DDS Lab – the private equity firm’s first acquisition in the US as a lead investor – to RoundTable Healthcare Partners for an undisclosed sum.
CITIC acquires China perfume brand
CITIC Capital has made an investment of undisclosed size in Shanghai Xiangmiao Trade, owner of Reclassified, a leading Chinese perfume and home fragrance brand.
Asia buyout managers see no shift in return targets - AVCJ Forum
Asia-focused buyout managers do not expect an economic downturn to impact the returns underwritten into investments at the portfolio level as long as leveraged financing remains competitively priced and new paths to liquidity continue to emerge.
CITIC exits data business to European GP
CITIC Capital is exiting its stake in business intelligence database provider ISI Emerging Markets Group to UK-based Montagu Private Equity.
Hillhouse, Boyu, CareCapital back condom maker
Chinese private equity firms Hillhouse Capital, Boyu Capital and CareCapital Partners, a specialist dental and consumer health investor, have paid $200 million for a 40% stake in condom brand LifeStyles.
Vision Fund leads $319m round for China's XtalPi
China and US-based artificial intelligence-enabled drug development platform XtalPi has raised $319 million in Series C funding led by SoftBank Vision Fund, the investment arm of insurer PICC Group, and Morningside Venture Capital.
CITIC, SF Holdings raise $308m China logistics fund
CITIC Capital and SF Holdings – the parent company of SF Express, China’s second-largest courier company – have launched a RMB2.1 billion ($308 million) fund that will invest in logistics properties.
GPs sell Wall Street English China business back to founder
Baring Private Equity Asia and CITIC Capital have sold the China-based assets of English language training provider Wall Street English (WSE) back to the original founder after COVID-19 called into question the business model.
Uncertainty deters distress investors - M&A Forum
Distress-focused investors warned that persistent economic uncertainty is making it difficult to act on opportunities even as companies run into trouble because of the coronavirus pandemic.
Profile: CITIC Capital's Hanxi Zhao
CITIC Capital’s Hanxi Zhao cut her teeth with brands in China at Procter & Gamble more than 20 years ago. The market has since moved on, but the underlying message has not
PE-backed Hygeia completes $286m Hong Kong IPO
Chinese radiotherapy business Hygeia Healthcare, which counts Warburg Pincus, Boyu Capital, and CITIC Capital among its investors, raised HK$2.22 billion ($286.4 million) in its Hong Kong IPO.
China's Miaoshou Doctor raises $85m
Miaoshou Doctor, a Chinese online healthcare services platform, has raised RMB600 million ($85 million) in the first tranche of Series D funding round backed by the likes of Qiming Venture Partners, Sequoia Capital China, Ince Capital Partners, CITIC...
Chinese drug developer Mabworks raises $159m Series C
Beijing Mabworks Biotech has raised a RMB1.13 billion ($159 million) Series C round led by CICC Capital, Lyzz Capital, CITIC Securities Investment, and Huge Capital.
PE targets sensual wellness: Good vibrations
A recent commitment by China’s CDH Investments to Wow Tech underlines how sensual health products such as vibrators are moving from the margins to the mainstream, globally and in Asia
CITIC, CDH, Legend invest $300m in China freight business
CITIC Capital, CDH investments and Legend Capital have invested $300 million in SF Freight, a sub-brand of Chinese courier company SF Express, through a convertible note issue.
CITIC Capital targets OBOR deals with blank check company
CITIC Capital has launched a special purpose acquisition vehicle (SPAC) – or blank check company – on the New York Stock Exchange to pursue deals under its One Belt One Road (OBOR) strategy.